Hypoxia-induced PIM kinase and laminin-activated integrin α6 mediate resistance to PI3K inhibitors in bone-metastatic CRPC

Bone-metastatic castration-resistant prostate cancer (CRPC) is lethal due to inherent resistance to androgen deprivation therapy, chemotherapy, and targeted therapies. Despite the fact that a majority of CRPC patients (approximately 70%) harbor a constitutively active PI3K survival pathway, targetin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Clin Exp Urol
Main Authors: Toth, Rachel K, Tran, Jack D, Muldong, Michelle T, Nollet, Eric A, Schulz, Veronique V, Jensen, Corbin C, Hazlehurst, Lori A, Corey, Eva, Durden, Donald, Jamieson, Christina, Miranti, Cindy K, Warfel, Noel A
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734039/
https://ncbi.nlm.nih.gov/pubmed/31511835
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados